About Mark Bakken
Form D filings for RxLightning in 2023 list Mark Bakken as director.
Mark Bakken first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Mark Bakken in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Mark Bakken works with at each company, as listed on that company's latest Form D.
RxLightning, Inc. · Form D, Jun 6, 2023
JK
Jared Klingeisen
Executive officer
BF
Bradley Fluegel
Director
JR
Julia Regan
President and director
JF
Josh Flum
Director
KB
Kathleen Bresette
Executive officer
CW
Carrie Williams
Director
BA
Brad Allen
Executive officer